Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
7.02
+0.28 (4.18%)
Aug 8, 2025, 11:34 AM - Market open

Sumo Logic Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-15.75-15.02-15.42-14.32-7.71-3.58
Upgrade
Depreciation & Amortization
-00000
Upgrade
Loss (Gain) From Sale of Assets
----0.02--
Upgrade
Stock-Based Compensation
1.772.312.972.961.510.14
Upgrade
Other Operating Activities
---0.43-0.11--
Upgrade
Change in Accounts Payable
0.950.47-0.68-1.15-4.240.11
Upgrade
Change in Other Net Operating Assets
-0.41-0.080.16-0.43-0.850
Upgrade
Operating Cash Flow
-13.43-12.32-13.41-13.08-11.29-3.32
Upgrade
Capital Expenditures
-----0-
Upgrade
Sale of Property, Plant & Equipment
---0.170.45-
Upgrade
Investment in Securities
--17.14-16.6--
Upgrade
Investing Cash Flow
--17.14-16.430.45-
Upgrade
Issuance of Common Stock
8.665.51--0.39-
Upgrade
Other Financing Activities
-1.07-0.76--47.951.16
Upgrade
Financing Cash Flow
7.584.75--48.341.16
Upgrade
Net Cash Flow
-5.85-7.583.74-29.5137.49-2.16
Upgrade
Free Cash Flow
-13.43-12.32-13.41-13.08-11.29-3.32
Upgrade
Free Cash Flow Per Share
-34.92-36.88-44.68-44.32-77.31-47.87
Upgrade
Cash Income Tax Paid
000000
Upgrade
Levered Free Cash Flow
-7.63-6.86-7.77-7.07-1.99-0.82
Upgrade
Unlevered Free Cash Flow
-7.63-6.86-7.77-7.07-1.99-0.82
Upgrade
Change in Net Working Capital
-0.6-0.440.50.71-1.33-1.28
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q